Your browser doesn't support javascript.
loading
Mapping the self-association domains of ataxin-1: identification of novel non overlapping motifs.
Menon, Rajesh P; Soong, Daniel; de Chiara, Cesira; Holt, Mark; McCormick, John E; Anilkumar, Narayana; Pastore, Annalisa.
Afiliação
  • Menon RP; MRC National Institute for Medical Research, The Ridgeway , London , UK.
  • Soong D; Randall Division for Cell and Molecular Biophysics, New Hunt's House, King's College London , Guy's Campus, London , UK ; British Heart Foundation Centre of Research Excellence, King's College London , Denmark Hill Campus, London , UK.
  • de Chiara C; MRC National Institute for Medical Research, The Ridgeway , London , UK.
  • Holt M; Randall Division for Cell and Molecular Biophysics, New Hunt's House, King's College London , Guy's Campus, London , UK.
  • McCormick JE; MRC National Institute for Medical Research, The Ridgeway , London , UK.
  • Anilkumar N; British Heart Foundation Centre of Research Excellence, King's College London , Denmark Hill Campus, London , UK.
  • Pastore A; MRC National Institute for Medical Research, The Ridgeway , London , UK ; Department of Molecular Neuroscience, Institute of Psychiatry, King's College London , Denmark Hill Campus, London , UK.
PeerJ ; 2: e323, 2014.
Article em En | MEDLINE | ID: mdl-24711972
The neurodegenerative disease spinocerebellar ataxia type 1 (SCA1) is caused by aggregation and misfolding of the ataxin-1 protein. While the pathology correlates with mutations that lead to expansion of a polyglutamine tract in the protein, other regions contribute to the aggregation process as also non-expanded ataxin-1 is intrinsically aggregation-prone and forms nuclear foci in cell. Here, we have used a combined approach based on FRET analysis, confocal microscopy and in vitro techniques to map aggregation-prone regions other than polyglutamine and to establish the importance of dimerization in self-association/foci formation. Identification of aggregation-prone regions other than polyglutamine could greatly help the development of SCA1 treatment more specific than that based on targeting the low complexity polyglutamine region.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article